/AMIX
AMIX Stock - Autonomix Medical, Inc. Common Stock
Healthcare|Medical - DevicesNASDAQ
$0.63-0.92%
$0.01 (-0.92%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.69
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AMIX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.62 – $0.63
TARGET (TP)$0.72
STOP LOSS$0.58
RISK/REWARD1:2.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-2.86
52W High$4.58
52W Low$0.60
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A |
| Operating Income | $-11,588,000 | $-12,030,000 | $-1,990,000 | $-13,594,275 |
| Net Income | $-11,410,000 | $-15,426,000 | $-1,990,000 | $-13,328,715 |
| Net Margin | N/A | N/A | N/A | N/A |
| EPS | $-6.46 | $-21.10 | $-0.11 | $-0.71 |
Company Overview
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AMIXBeat Rate
75%
Last 4 quarters
Avg Surprise
+16.6%
EPS vs Estimate
Beats / Misses
3/1
Last 12 quarters
Latest EPS
$-1.38
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
+39.2%
$-1.46vs$-2.40
Q2 25
+40.3%
$-0.74vs$-1.24
Q3 25
-20.9%
$-1.07vs$-0.89
Q4 25
+8.0%
$-1.38vs$-1.50
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 12, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | $-1.50 | $-1.38 | +8.0% | ✓ BEAT |
Q3 2025 | Aug 13, 2025 | $-0.89 | $-1.07 | -20.9% | ✗ MISS |
Q2 2025 | May 29, 2025 | $-1.24 | $-0.74 | +40.3% | ✓ BEAT |
Q1 2025 | Feb 13, 2025 | $-2.40 | $-1.46 | +39.2% | ✓ BEAT |
Q4 2024 | Nov 8, 2024 | — | $-2.47 | — | — |
Q3 2024 | Aug 13, 2024 | — | $-0.14 | — | — |
Q2 2024 | May 31, 2024 | — | $-6.20 | — | — |
Q1 2024 | Feb 13, 2024 | — | $-0.23 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.17 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.05 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.03 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.03 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.03 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.66 | — | — |
Latest News
Autonomix Medical Prices Private Placement At Combined offering Price Of $1.1107 for Gross Proceeds $5M
➖ NeutralBenzinga•Nov 18, 2025, 01:35 PM
Autonomix Medical shares are trading higher after the company reported post-hoc subgroup analysis results from its first-in-human study showing potential quality-of-life improvements with its targeted ablation therapy.
📈 PositiveBenzinga•Nov 17, 2025, 01:02 PM
Autonomix Medical, Announces Results From Post-Hoc Exploratory Subgroup Analysis; Says EORTC QLQ-C30 Subgroup Results Confirm Broad And Durable Quality-Of-Life Improvements Across Disease Stages And Metastasis Status
📈 PositiveBenzinga•Nov 17, 2025, 01:02 PM
Autonomix Medical To Present At TCT 2025 Conference Showcasing Initial Results From Its First-in-Human Study On Transvascular Nerve-Targeted Therapy To Reduce Pancreatic Cancer Pain
📈 PositiveBenzinga•Oct 24, 2025, 01:05 PM
Autonomix To Highlight Nerve-Sensing And Ablation Platform At 2025 Maxim Growth Summit In New York
📈 PositiveBenzinga•Oct 16, 2025, 01:20 PM
Autonomix Secures New U.S. Patent Titled, "Controlled And Precise Treatment Of Cardiac Tissues"
📈 PositiveBenzinga•Oct 9, 2025, 12:46 PM
Autonomix Medical Commences GLP Preclinical Study Required By FDA At CBSET For Sensing And RF Ablation System As Treatment For Pancreatic Cancer Pain
📈 PositiveBenzinga•Sep 29, 2025, 01:54 PM
Autonomix Medical Announces Extended Post Hoc Data From First-In-Human Study On Transvascular Nerve Ablation For Pancreatic Cancer Pain Relief
📈 PositiveBenzinga•Sep 3, 2025, 12:41 PM
Autonomix Medical shares are trading higher after the company announced it entered into a $15 million purchase agreement.
📈 PositiveBenzinga•Aug 26, 2025, 04:55 PM
Autonomix Medical Enters $15M Common Stock Purchase Agreement With Lincoln Park Capital, Effective Over 24 Months; Pending SEC Approval
📈 PositiveBenzinga•Aug 26, 2025, 04:53 PM
European Patent Office Grants Autonomix Medical Patent No. 3,697,298 Titled, "Medical Device with Circuitry for Capturing and Processing Physiological Signals.
📈 PositiveBenzinga•Aug 20, 2025, 12:34 PM
Frequently Asked Questions about AMIX
What is AMIX's current stock price?
Autonomix Medical, Inc. Common Stock (AMIX) is currently trading at $0.63 per share. The stock has moved -0.92% today.
What is the analyst price target for AMIX?
No analyst price targets are currently available for this stock.
What sector is Autonomix Medical, Inc. Common Stock in?
Autonomix Medical, Inc. Common Stock operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is AMIX's market cap?
Autonomix Medical, Inc. Common Stock has a market capitalization of $0.00 billion, making it a small-cap company.
Does AMIX pay dividends?
No, Autonomix Medical, Inc. Common Stock does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAIM
AIM ImmunoTech Inc.
$1.42
Mkt Cap: $0.0B
BBLG
Bone Biologics Corporation
$1.83
Mkt Cap: $0.0B
DHAI
DIH Holding US, Inc.
$0.00
Mkt Cap: $0.0B
FLGC
Flora Growth Corp.
$7.31
Mkt Cap: $0.0B
HSCS
HeartSciences Inc.
$2.36
Mkt Cap: $0.0B
KALA
KALA BIO, Inc.
$0.62
Mkt Cap: $0.0B
MOVE
Movano Inc.
$8.39
Mkt Cap: $0.0B
NAOV
NanoVibronix, Inc.
$4.02
Mkt Cap: $0.0B
OGEN
Oragenics, Inc.
$0.88
Mkt Cap: $0.0B
VERO
Venus Concept Inc.
$1.92
Mkt Cap: $0.0B
Explore stocks similar to AMIX for comparison